When tumors reached a mean volume of ~ 300 mm3, mice were assigned to the following treatment groups: administration of PBS, untransduced T cells, or NKG2D CAR (+) T cells on day 40 and day 45 after tumor implantation by tail-vein injection. Here, KLRK1 is linked to neoplasm.